Gunsynd Regulatory News (GUN)

8 Jan 2007 17:57

Syntopix Group plc08 January 2007 SYNTOPIX GROUP plc ("the Company") Notification of Change in Interests of Directors On 8 January 2007 options ("Options") were granted to directors of the Companyin respect of an aggregate of 85,260 ordinary shares of 10p each in the Company("Ordinary Shares"). The Options, taken with existing options over OrdinaryShares, will, if exercised, represent 1.38 per cent. of the then enlarged issuedshare capital of the Company. All Options were granted with an exercise price of176.5p per Ordinary Share (the closing mid-market price on 3 January 2007). Noamounts were paid for the grants themselves. Dr Rod Adams was granted 56,840 Options, which will vest on 18 January 2008 onthe condition that Dr Adams remains Chairman of the Company at that date.Following this announcement Dr Adams holds 183,485 Ordinary Shares (3.28% of theexisting issued share capital) and 56,840 options over Ordinary Shares in thecapital of the Company. These Options, taken with existing options over OrdinaryShares, will, if exercised, represent 0.92 per cent. of the then enlarged issuedshare capital of the Company. Darren Bamforth was granted 14,210 Options, which will vest on 18 January 2008on the condition that Mr Bamforth continues in the position of Finance Directorinto the second year following the flotation of the Company. Following thisannouncement Mr Bamforth holds 2,825 Ordinary Shares (0.05% of the existingissued share capital) and 42,630 options over Ordinary Shares in the capital ofthe Company. These Options, taken with existing options over Ordinary Shares,will, if exercised, represent 0.23 per cent. of the then enlarged issued sharecapital of the Company. Dr Helen Shaw was granted 14,210 Options, which will vest on 18 July 2007.Following this announcement Dr Shaw holds no Ordinary Shares and 42,630 optionsover Ordinary Shares in the capital of the Company. These Options, taken withexisting options over Ordinary Shares, will, if exercised, represent 0.23 percent. of the then enlarged issued share capital of the Company. Enquiries: Syntopix Group plc Dr Stephen Jones, Chief Executive Officer (01274 236621) Mr Darren Bamforth, Finance Director (01274 236621) This information is provided by RNS The company news service from the London Stock Exchange